MARY LEE: Open Payments
NPI 1295445575 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$359 in 18 payments from 11 companies in 2025. Trend: 2023 $195 · 2024 $280 · 2025 $359
Food & beverage: $359
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| Astellas Pharma US Inc | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Exact Sciences Corporation | 1 | $26 |
| Novo Nordisk Inc | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $19 |
Products named: TRELEGY ELLIPTA, Veozah, AIRSUPRA, CAPLYTA, GIVLAARI, The Cologuard Plus Collection Kit, BEVESPI AEROSPHERE, Ozempic.
Industry payments across AZ — which companies pay providers there.
